Stereotactic radiosurgery (SRS) is a non-invasive method of delivering a single, high-dose of radiation to a tumor. It is principally used to treat cancers of the brain that cannot be treated through surgery or used to treat brain tumor beds after surgery. Our doctors have collectively treated thousands of patients using SRS, and they were among the first in New Jersey and Pennsylvania to begin using BrainLAB based stereotactic radiosurgery, an enhancement in SRS that provides even greater targeting acccuracy and better results for our patient. SRS can be delivered often with minimal side effects.
To determine whether a patient is a good candidate for SRS, she or he will meet with both a radiation oncologist and a neurosurgeon. If SRS is determined to be the best course of treatment, the patient will undergo a special MRI. Prior to or on the day of the procedure, these MRI images will be combined with CT images using our BrainLAB technology. The scans and the fusion process ensure precise anatomical visualization of the tumor.
A comprehensive treatment plan will be created by the radiation oncologist, neurosurgeon, and physicist. SRS does not require hospital admission, and the patient may return home the same day.